Musculoskeletal Diseases clinical trials

Explore recruiting musculoskeletal diseases clinical trials.

Recruiting musculoskeletal diseases studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Musculoskeletal Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of each of two dose levels of sarilumab in adults with early polymyalgia rheumatica

France, Netherlands, Germany, Czechia, Belgium, Austria +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

J1A-MC-KDAF: A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants with Moderately-to-Severely Active Rheumatoid Arthritis

Hungary, Spain, Italy, Poland, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

Hyperbaric Oxygen Therapy in Hamstring injury (HOTHAM) trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Feasibility of short-term temporary discontinuation of serotonin reuptake inhibitors in patients planned for hip or knee arthroplasty

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

Randomized Clinical Trial for the Treatment of Lateral Epicondylitis with Debridement Arthroscopic Versus Cytokine-Rich Autologous Serum. (SARC)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A trial of prednisolone in combination with SPI-62 or placebo in participants with polymyalgia rheumatica (PMR)

Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Musculoskeletal Diseases trials by city

Musculoskeletal Diseases in Toronto Musculoskeletal Diseases in Vancouver Musculoskeletal Diseases in Montreal Musculoskeletal Diseases in Calgary Musculoskeletal Diseases in Edmonton Musculoskeletal Diseases in Ottawa Musculoskeletal Diseases in Winnipeg Musculoskeletal Diseases in Quebec City Musculoskeletal Diseases in Hamilton Musculoskeletal Diseases in Kitchener Musculoskeletal Diseases in London Musculoskeletal Diseases in Halifax Musculoskeletal Diseases in New York Musculoskeletal Diseases in Los Angeles Musculoskeletal Diseases in Chicago Musculoskeletal Diseases in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease